Literature DB >> 8443521

Diagnostic dilatation and curettage: is it used appropriately?

A Coulter1, A Klassen, I Z MacKenzie, K McPherson.   

Abstract

OBJECTIVE: To determine patterns of use of dilatation and curettage in Britain as compared with those in the United States; to examine variations in utilisation rates within one regional health authority.
DESIGN: Analysis of routinely collected hospital inpatient statistics.
SETTING: Statistics for England, Scotland, and the United States; local statistics for Oxford region.
SUBJECTS: All inpatient episodes in which dilatation and curettage was performed but excluding those related to pregnancy.
RESULTS: Dilatation and curettage rates remained stable in Britain between 1977 and 1990, whereas in the United States they declined dramatically. In 1989-90 the rate was 71.1 per 10,000 women in England as compared with only 10.8 per 10,000 in America. In 1989, 6936 women underwent diagnostic dilatation and curettage in the Oxford region, making it the most common elective operation. A total of 2726 (39%) of these women were under 40. There was a more than twofold variation in usage of the procedure among district health authorities within the region and even greater variation in rates in women under 40. The proportion of patients treated as day cases in the district general hospitals ranged from 22% to 82%.
CONCLUSIONS: Dilatation and curettage may frequently be used inappropriately. The considerable variations in usage of dilatation and curettage internationally and nationally indicate differences in clinical perception of its appropriateness. This makes it suitable for audit. In developing guidelines it will be important to agree on the most appropriate patients and the relative merits of alternative methods of endometrial sampling. Probably this could result in considerable cost savings at no risk and possibly some benefit to patients.

Entities:  

Mesh:

Year:  1993        PMID: 8443521      PMCID: PMC1676730          DOI: 10.1136/bmj.306.6872.236

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


  32 in total

1.  Hysteroscopy with selective endometrial sampling compared with D&C for abnormal uterine bleeding: the value of a negative hysteroscopic view.

Authors:  F D Loffer
Journal:  Obstet Gynecol       Date:  1989-01       Impact factor: 7.661

2.  Hysteroscopic findings after unsuccessful dilatation and curettage for abnormal uterine bleeding.

Authors:  P G Brooks; S P Serden
Journal:  Am J Obstet Gynecol       Date:  1988-06       Impact factor: 8.661

3.  Uterine microcurettage with combined endometrial histopathology and cytology. An alternative to conventional curettage.

Authors:  O Löfgren; P Alm; A Ionescu; J Skjerris
Journal:  Acta Obstet Gynecol Scand       Date:  1988       Impact factor: 3.636

4.  Current dilatation and curettage practice: a need for revision.

Authors:  J J Smith; H Schulman
Journal:  Obstet Gynecol       Date:  1985-04       Impact factor: 7.661

5.  A comparative study between panoramic hysteroscopy with directed biopsies and dilatation and curettage. A review of 276 cases.

Authors:  R J Gimpelson; H O Rappold
Journal:  Am J Obstet Gynecol       Date:  1988-03       Impact factor: 8.661

6.  Critical review of dilatation and curettage in the diagnosis of malignant pathology of the endometrium.

Authors:  S Danero; M G Ricci; R La Rosa; C Massafra; F Franchi; C Pitino; M Giovani; G L Onnis
Journal:  Eur J Gynaecol Oncol       Date:  1986       Impact factor: 0.196

7.  Hysteroscopy in perimenopausal and postmenopausal women with abnormal uterine bleeding.

Authors:  L Mencaglia; A Perino; J Hamou
Journal:  J Reprod Med       Date:  1987-08       Impact factor: 0.142

8.  Routine outpatient diagnostic uterine curettage using a flexible plastic aspiration curette.

Authors:  I Z MacKenzie
Journal:  Br J Obstet Gynaecol       Date:  1985-12

9.  Declining surgical case-load of the obstetrician-gynecologist.

Authors:  D A Grimes
Journal:  Obstet Gynecol       Date:  1986-06       Impact factor: 7.661

10.  Diagnostic endometrial aspiration with the Karman cannula.

Authors:  R A Suarez; D A Grimes; B Majmudar; B B Benigno
Journal:  J Reprod Med       Date:  1983-01       Impact factor: 0.142

View more
  22 in total

1.  Profiling outpatient workload: practice variations between consultant firms and hospitals in south west England.

Authors:  A C Faulkner; I M Harvey; T J Peters; D J Sharp; S J Frankel
Journal:  J Epidemiol Community Health       Date:  1997-06       Impact factor: 3.710

2.  Cost-per-QALY league tables: their role in pharmacoeconomic analysis.

Authors:  J M Mason
Journal:  Pharmacoeconomics       Date:  1994-06       Impact factor: 4.981

Review 3.  Managing menorrhagia.

Authors:  A Coulter; A Long; J Kelland; S O'Meara; M Sculpher; F Song; T A Sheldon
Journal:  Qual Health Care       Date:  1995-09

4.  Changing the measure of quality in the NHS: from purchasing activity to purchasing protocols.

Authors:  T A Sheldon; M Borowitz
Journal:  Qual Health Care       Date:  1993-09

5.  Incidence of endometrial hyperplasia.

Authors:  Susan D Reed; Katherine M Newton; Walter L Clinton; Meira Epplein; Rochelle Garcia; Kimberly Allison; Lynda F Voigt; Noel S Weiss
Journal:  Am J Obstet Gynecol       Date:  2009-04-23       Impact factor: 8.661

6.  Hepatic resection in Canada: rates and geographic variation.

Authors:  Ryan J McColl; Balpreet Brar; William A Ghali; Elijah Dixon
Journal:  Can J Surg       Date:  2009-12       Impact factor: 2.089

7.  Endometrial sampling in general practice.

Authors:  C J Seamark
Journal:  Br J Gen Pract       Date:  1998-09       Impact factor: 5.386

Review 8.  The demise of the D&C.

Authors:  C J Seamark
Journal:  J R Soc Med       Date:  1998-02       Impact factor: 5.344

9.  Endometrial pipelle biopsy compared to conventional dilatation and curettage.

Authors:  S Ong; T Duffy; P Lenehan; J Murphy
Journal:  Ir J Med Sci       Date:  1997 Jan-Mar       Impact factor: 1.568

10.  Providers' experiences treating chronic pain among opioid-dependent drug users.

Authors:  Karina M Berg; Julia H Arnsten; Galit Sacajiu; Alison Karasz
Journal:  J Gen Intern Med       Date:  2009-02-03       Impact factor: 5.128

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.